Effect on Vitamin D supplements and Fatty Acids in management of cardiovascular diseases
Main Article Content
Keywords
Vitamin D, fatty acids, polyunsaturated fatty acids, cardiovascular diseases
Abstract
Introduction: n-3 polyunsaturated fatty acids (PUFA) and vitamin D exclusively and have been the focus of numerous research regarding their possible significance in lowering cardiovascular risk. Numerous physiological processes, including signal transduction, ion channel kinetics, and protein and membrane trafficking are modulated in part by lipid microdomains. The inclusion of n-3 PUFA
modifies the physical characteristics of cellular and organelle membrane structures and affects the positioning, functioning, and signaling of membrane-associated proteins.
Aims and Objectives: To analyze the effect of vitamin D supplements and fatty acids on the management of cardiovascular diseases.
Methods: This is a prospective study which was conducted on 80 patients for whom cardiovascular abnormalities were considered and their parameters were determined before administration of n3 fatty acids and Vitamin D3. After 6 months course of drugs containing n3 fatty acids and Vitamin D3, the cardiovascular abnormalities including mortality were assessed for end outcome. The statistical
analysis was conducted to determine the significance of the improvement.
Results: The study found that end assessment showed that ischemic stroke (p=0.032) and cardiovascular mortality (p=0.023) were significantly found to be less in the n-3 FAs group and vitamin - D group compared to the control group.
Conclusion: The study concluded that administration of n-3 FAs group and vitamin - D at a mentioned dosage for 6 months may lead to a statistically significant reduction in cardiovascular mortality and ischemic stroke as compared to healthy controls.
References
2. Reddy Vanga S, Good M, Howard PA, Vacek JL. Role of vitamin D in cardiovascular health. American Journal of Cardiology. 2010;106(6):798–805.
3. Levin A, Li YC. Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? Kidney
International. 2005;68(5):1973–1981.
4. Artaza JN, Mehrotra R, Norris KC. Vitamin D and the cardiovascular system. Clinical Journal of the American Society of Nephrology.
2009;4(9):1515–1522.
5. Wu-Wong JR, Nakane M, Ma J, Ruan X, Kroeger PE. Effects of Vitamin D analogs on gene expression profiling in human coronary
artery smooth muscle cells. Atherosclerosis. 2006;186(1):20–28.
6. Lee JH, O’Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency. An important, common, and easily treatable cardiovascular risk factor? Journal of the American College of Cardiology. 2008;52(24):1949–1956.
7. Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. Journal of
Nutritional Biochemistry. 2010;21(9):781–792.
8. O’Keefe JH, Jr., Abuissa H, Sastre A, Steinhaus DM, Harris WS. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. American Journal of Cardiology. 2006;97(8):1127–1130.
9. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008 Jun 9;168(11):1174–1180.
10. Zittermann A, Koerfer R. Vitamin D in the prevention and treatment of coronary heart disease. Curr Opin Clin Nutr Metab Care. 2008 Nov;11(6):752–757.
11. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d
levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008 Jun 23;168(12):1340–1349.
12. Christensen JH, Schmidt EB. n-3 fatty acids and the risk of sudden cardiac death. Lipids. 2001;36, supplement:S115–S118.
13. Heidt MC, Vician M, Stracke SK, et al. Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study. The Thoracic and Cardiovascular Surgeon. 2009;57(5):276–280.
14. Harris WS, Bulchandani D. Why do omega-3 fatty acids lower serum triglycerides? Current Opinion in Lipidology. 2006;17(4):387–393.
15. Leaf A, Kang JX, Xiao YF, Billman GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism
of prevention of arrhythmias by n-3 fish oils. Circulation. 2003;107(21):2646–2652.
16. O’Keefe JH, Jr., Abuissa H, Sastre A, Steinhaus DM, Harris WS. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. American Journal of Cardiology. 2006;97(8):1127–1130.
17. Kenny D, Warltier DC, Pleuss JA, Hoffmann RG, Goodfriend TL, Egan BM. Effect of omega3 fatty acids on the vascular response to
angiotensin in normotensive men. American Journal of Cardiology. 1992;70(15):1347–1352.
18. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSIPrevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. (1999). Lancet (London, England), 354(9177), 447–455. https://pubmed.ncbi.nlm.nih.gov/10465168/
19. Reddy Vanga, S., Good, M., Howard, P. A., & Vacek, J. L. (2010). Role of Vitamin D in Cardiovascular Health. The American Journal of
Cardiology, 106(6), 798–805. https://doi.org/10.1016/j.amjcard.2010.04.042
20. Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. The Lancet. 2007;369(9567):1090–1098.
21. Rauch B, Schiele R, Schneider S, et al. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation. 2010;122(21):2152–2159.
22. Kromhout D, Giltay EJ, Geleijnse JM. n-3 fatty acids and cardiovascular events after myocardial infarction. The New England Journal of Medicine. 2010;363(21):2015–2026.
23. O’Keefe JH, Jr., Abuissa H, Sastre A, Steinhaus DM, Harris WS. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. American Journal of Cardiology. 2006;97(8):1127–1130.
24. Christensen JH, Gustenhoff P, Korup E, et al. Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. British Medical Journal. 1996;312(7032):677–678.
25. Kromhout D, Giltay EJ, Geleijnse JM. n-3 fatty acids and cardiovascular events after myocardial infarction. The New England Journal of Medicine. 2010;363(21):2015–2026.
26. Schiano V, Laurenzano E, Brevetti G, et al. Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function. Clinical Nutrition. 2008;27(2):241–247.
27. Nodari S, Triggiani M, Campia U, et al. Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. Journal of the American College of Cardiology. 2011;57(7):870–879.
28. Mahdi, E. M., & Mustafa, M. A. (2022). Effect of different concentrations of extract of Urtica dioica and Cladosporium cladosporiodes on Tribolium castaneum or: Coleoptera after 24-48 hours of exposure in Samarra City/Iraq. HIV Nursing, 22(2), 3207-3210.
29. Mustafa, M. A., Kadham, S. M., Abbass, N. K., Karupusamy, S., Jasim, H. Y., Alreda, B. A., & Ahmed, M. T. (2023). A novel fuzzy Mtransform technique for sustainable ground water level prediction. Applied Geomatics, 1-7.
30. Kadham, S. M., Mustafa, M. A., Abbass, N. K., & Karupusamy, S. (2022). IoT and artificial intelligence–based fuzzy-integral N-transform for sustainable groundwater management. Applied Geomatics, 1-8.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.